US 11591332
IRAK degraders and uses thereof
granted A61KA61K45/06A61P
Quick answer
US patent 11591332 (IRAK degraders and uses thereof) held by Kymera Therapeutics, Inc. expires Mon Feb 23 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Kymera Therapeutics, Inc.
- Grant date
- Tue Feb 28 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 23 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61K, A61K45/06, A61P, A61P27/02, A61P29/00